AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Glenmark Pharmaceuticals ltd Major Shareholding Notification 2022

Apr 8, 2022

Preview isn't available for this file type.

Download source file

Regulation 31(4)- Annual Declar

Disclosure regulation	Symbol	Name of the Company	Name of the Entity/Person	Category	Financial Year End
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Glenn Mario Saldanha	Promoter	31-Mar-2022
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Blanche Elizabeth Saldanha	Promoter	31-Mar-2022
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Cherylann Maria Pinto	Promoter	31-Mar-2022
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Saldanha Family Trust	Promoter	31-Mar-2022
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Robin Pinto	Promoter Group	31-Mar-2022
Reg 31(4)	GLENMARK	Glenmark Pharmaceuticals Limited	Neha Saldanha	Promoter Group	31-Mar-2022